Epidural anesthesia? No of course

Area of Science:

• Anesthesiology
• Surgical Outcomes
• Hepatobiliary Surgery

Background:

• Thoracic epidural anesthesia (TEA) benefits are debated, with past studies yielding equivocal results.
• Increasing use of antithrombotic drugs and aging populations complicate neuroaxial anesthesia guidelines.
• Hepatectomy significantly alters coagulation profiles, necessitating specific considerations for TEA.

Purpose of the Study:

• To evaluate the role and safety of thoracic epidural anesthesia (TEA) in surgical patients, particularly after hepatectomy.
• To highlight the need for individualized TEA decision-making based on comprehensive patient assessment.
• To emphasize careful management of TEA in the context of altered coagulation profiles.

Main Methods:

• Review of existing literature on TEA efficacy and contraindications.
• Analysis of TEA's impact on mortality and morbidity in specific surgical subgroups.
• Discussion of neuroaxial guidelines in relation to post-hepatectomy coagulation changes.

Main Results:

• TEA provides analgesia and can decrease mortality and morbidity in certain patient groups.
• Complications, though rare, can have disproportionately severe consequences.
• Standard neuroaxial guidelines do not adequately address the dynamic coagulation changes post-hepatectomy.

Conclusions:

• Individualized assessment of contraindications, comorbidities, coagulation, hepatic reserve, and risk-benefit balance is essential for TEA decisions in liver surgery.
• TEA catheter insertion/removal requires adherence to guidelines and normal thromboelastography (TEG).
• Close monitoring of prothrombin content and platelet counts is vital in the 2-5 days following hepatectomy.